- Home
- VALN vs NBB Comparison
VALN vs NBB Comparison
Compare VALN & NBB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VALN | NBB |
|---|---|---|
| Founded | 2012 | N/A |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 537.8M | 462.4M |
| IPO Year | 2021 | 2010 |
Fundamental Metrics
Financial Performance| Metric | VALN | NBB |
|---|---|---|
| Price | $6.10 | $15.73 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $15.75 | N/A |
| AVG Volume (30 Days) | ★ 128.2K | 57.8K |
| Earning Date | 05-06-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $4.00 | N/A |
| Revenue Next Year | $92.04 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.43 | $14.52 |
| 52 Week High | $12.25 | $16.62 |
Technical Indicators
Market Signals| Indicator | VALN | NBB |
|---|---|---|
| Relative Strength Index (RSI) | 25.51 | 50.88 |
| Support Level | $5.69 | $15.47 |
| Resistance Level | $6.73 | $15.99 |
| Average True Range (ATR) | 0.38 | 0.24 |
| MACD | -0.33 | 0.03 |
| Stochastic Oscillator | 1.11 | 83.87 |
Price Performance
Historical ComparisonAbout VALN Valneva SE
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.
About NBB Nuveen Taxable Municipal Income Fund of Beneficial Interest
Nuveen Taxable Municipal Income Fund is a closed-end fund incorporated in the United States. Its primary objective is current income through investments in taxable municipal securities; the secondary objective is to seek enhanced portfolio value and total return. The fund invests a majority of its assets in a diversified portfolio of taxable municipal securities.